Retatrutide
Retatrutide is an investigational peptide that has been studied in clinical and preclinical research in relation to metabolic signalling, body-composition research, and energy regulation. It is a triple agonist that has been investigated for its activity at GLP-1, GIP, and glucagon receptors.
Research Areas
Research into retatrutide may include:
- GLP-1 receptor signalling research;
- GIP receptor signalling research;
- Glucagon receptor signalling research;
- Metabolic research;
- Body-composition research;
- Appetite and satiety signalling research;
- Energy expenditure research;
- Lipid metabolism research;
- Glucose regulation research;
- Adipose-tissue research;
- Preclinical research;
- Clinical research.
Retatrutide has been studied in laboratory, preclinical, and clinical settings and should not be interpreted as proof of safety or therapeutic effectiveness in humans.
Retatrutide is supplied by Amino Bound for laboratory research purposes only. It is not intended for human consumption, human administration, veterinary use, diagnosis, treatment, prevention, or cure of any disease or medical condition.
Further research and appropriate scientific evaluation are needed to understand the safety, pharmacology, and possible applications of retatrutide outside approved research settings.